New Delhi, November 07, 2023: A new therapeutic drug formulation (TDF) comprising of low doses of commercial equine anti-scorpion antivenom (ASA), α1- adrenoreceptor agonist (AAAs) and vitamin C, for inhibiting the Indian red scorpion venom-induced toxicity and associated symptoms can help improve clinical management of scorpion sting patients. Scorpion envenomation is a severe problem in […]
Tag: treatment
Potential treatment route for Alzheimer’s disease found in natural polyphenol
New Delhi, Sept 21, 2023: Scientists have found that highly abundant naturally occurring plant-based polyphenols (PPs) like tannic acid found in twigs of trees like Chestnut and Oak can modulate the ferroptosis-AD axis to yield a safe, cost-effective strategy for combating Alzheimer’s disease (AD) and reduce the societal burden of this debilitating neurodegenerative disorder. AD […]
Doctors may soon diagnose peptic ulcer, disease stage by recognising breath patterns
New Delhi, June 30, 2023: A newly developed non-invasive method of recognising breath patterns can help rapid, one-step diagnosis and classification of various gastric disorders like dyspepsia, gastritis, and gastroesophageal reflux disease (GERD). Currently, peptic ulcer disease is an important medical-social problem that has received special attention all over the world. Helicobacter pylori bacterial infection is considered […]
A drug delivery solution can improve cancer management and treatment
New Delhi, October 13, 2022: A novel site-specific drug delivery method using gold nanoparticles can improve the management and treatment of cancer. There are more than 200 different types of cancers known which are currently being treated through surgery, chemotherapy, and radiation therapy. Many of these cancers can be cured if detected early and treated […]
Newly identified gene could be clue to treatment of fungal infection in immuno-compromised patients
New Delhi, August 30, 2022: A newly identified gene can hold the key to prevent fungal infection Candidiasis that often affects intensive-care unit (ICU) patients, cancer patients and patients receiving immunosuppressive therapy. The gene called CSA6 has been identified in Candida albicans a fungal species infamous for causing high rates of morbidity and mortality under […]
Hydrophobic ingredients, in combination with obsolete antibiotics, can counter multidrug-resistant bacteria
New Delhi, August 03, 2022: A new ingredient that can weakly perturb bacterial membrane, thus countering bacterial resistance to multiple classes of antibiotics, can help revive the efficacy of obsolete antibiotics. This strategy can combat the most critical group of bacteria enabling the existing antibiotic arsenal to be used again for complicated infections. It can […]
Multi-sectorial strategies for the prevention and control of pollen allergy
New Delhi, April 06, 2022: Indian Scientists have suggested that large scale measures like developing pollen forecast systems and training of health care professionals and personal measures like following pollen forecasts, use of face masks, spectacles, and air filters, regularly taking prescribed medications, limiting outdoor exposure, and avoiding gardening or grass-cutting during peak pollen seasons could help minimize the onset and […]
Cases of Fairbank’s disease and acromegaly in India
New Delhi, February 21, 2022: Acromegaly disease has been addressed by the Government of India. Fairbank’s disease (Multiple epiphyseal dysplasia) patients usually requires management of pain and orthopedic procedures, for which facilities are available at tertiary care institutions in India. Another rare disorder, Acromegaly is caused by excessive secretion of growth hormone, most often from […]
Tata Memorial Centre Publishes Study on the Treatment of Oral Cancer In India
New Delhi, June 20, 2021: According to the World Health Organization (WHO), cancer is the second leading cause of death globally, with approximately 70% cancer cases occurring in low and middle-income countries. India’s cancer scenario is burdened with oral cavity cancer being the most common among men. In fact, India accounted for almost a third […]
COVID-19: DCGI approves Phase II+III trials of Oxford University vaccine
The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India. This will hasten the development of the COVID-19 vaccine. India continues to improve the Case Fatality Rate (CFR), and maintain its global position of […]